Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85


Haplo-BMT: which approach?

Velardi A.

Blood. 2013 Jan 31;121(5):719-20. doi: 10.1182/blood-2012-12-469981.


Cost and outcome in stem cell collections in HLA-haplo identical/mismatched related transplantation with combined granulocyte-colony stimulating factor-mobilized blood and bone marrow for patients with hematologic malignancies.

Chen XH, Zhang C, Zhang X, Gao L, Gao L, Kong PY, Peng XG, Sun AH, Zeng DF, Wang QY.

Transfus Apher Sci. 2010 Aug;43(1):23-8. doi: 10.1016/j.transci.2010.05.003. Epub 2010 Jun 15.


Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies.

Di Bartolomeo P, Santarone S, De Angelis G, Picardi A, Cudillo L, Cerretti R, Adorno G, Angelini S, Andreani M, De Felice L, Rapanotti MC, Sarmati L, Bavaro P, Papalinetti G, Di Nicola M, Papola F, Montanari M, Nagler A, Arcese W.

Blood. 2013 Jan 31;121(5):849-57. doi: 10.1182/blood-2012-08-453399. Epub 2012 Nov 19.


Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.

Chen XH, Zhang C, Zhang X, Gao L, Gao L, Kong PY, Peng XG, Qi DG, Sun AH, Zeng DF, Liu H, Gong Y, Wang QY.

Biol Blood Marrow Transplant. 2009 Feb;15(2):266-73. doi: 10.1016/j.bbmt.2008.11.029. Erratum in: Biol Blood Marrow Transplant. 2009 Apr;15(4):521.


A novel approach to human leukocyte antigen-mismatched transplantation in patients with malignant hematological disease.

Huang XJ, Han W, Xu LP, Chen YH, Liu DH, Lu J, Chen H, Zhang YC, Jiang Q, Liu KY, Lu DP.

Chin Med J (Engl). 2004 Dec;117(12):1778-85.


Haematological malignancies in sibling and unrelated donors of allogeneic peripheral stem cells mobilised with G-CSF filgrastim: a transplant centre and Czech National Marrow Donors Registry experience.

Vokurka S, Koza V, Jungova A, Navratilova J, Svoboda T, Jindra P, Steinerova K, Vyrutova R.

Bone Marrow Transplant. 2012 Jun;47(6):867-8. doi: 10.1038/bmt.2011.173. Epub 2011 Aug 29. No abstract available.


Is mobilized peripheral blood comparable with bone marrow as a source of hematopoietic stem cells for allogeneic transplantation from HLA-identical sibling donors? A case-control study.

Gallardo D, de la Cámara R, Nieto JB, Espigado I, Iriondo A, Jiménez-Velasco A, Vallejo C, Martín C, Caballero D, Brunet S, Serrano D, Solano C, Ribera JM, de la Rubia J, Carreras E.

Haematologica. 2009 Sep;94(9):1282-8. doi: 10.3324/haematol.2009.006924.


Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies.

Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W, Chen YH, Wang JZ, Gao ZY, Zhang YC, Jiang Q, Shi HX, Lu DP.

Bone Marrow Transplant. 2006 Aug;38(4):291-7. Erratum in: Bone Marrow Transplant. 2008 Aug;42(4):295. Dosage error in article text.


Hematopoietic growth factors for graft failure after bone marrow transplantation: a randomized trial of granulocyte-macrophage colony-stimulating factor (GM-CSF) versus sequential GM-CSF plus granulocyte-CSF.

Weisdorf DJ, Verfaillie CM, Davies SM, Filipovich AH, Wagner JE Jr, Miller JS, Burroughs J, Ramsay NK, Kersey JH, McGlave PB, et al.

Blood. 1995 Jun 15;85(12):3452-6.


The inferiority of G-PB to rhG-CSF-mobilized blood and marrow grafts as a stem cell source in patients with high-risk acute leukemia who underwent unmanipulated HLA-mismatched/haploidentical transplantation: a comparative analysis.

Xu LP, Liu KY, Liu DH, Chen H, Han W, Chen YH, Wang Y, Huang XJ.

Bone Marrow Transplant. 2010 Jun;45(6):985-92. doi: 10.1038/bmt.2009.311. Epub 2009 Nov 9.


Late G-CSF after allogeneic bone marrow or peripheral blood stem cell transplantation: a prospective controlled trial.

Himmelmann B, Himmelmann A, Furrer K, Halter J, Schanz U.

Bone Marrow Transplant. 2002 Oct;30(8):491-6.


Factors influencing engraftment in HLA-haploidentical/mismatch related transplantation with combined granulocyte-colony stimulating factor-mobilized peripheral blood and bone marrow for patients with leukemia.

Zhang C, Zhang X, Chen XH, Gao L, Gao L, Kong PY, Peng XG, Sun AH, Wang QY.

Transfus Apher Sci. 2011 Jun;44(3):249-55. doi: 10.1016/j.transci.2011.04.005. Epub 2011 May 6.


Long-term follow-up after allogeneic granulocyte colony-stimulating factor--primed bone marrow transplantation.

Isola L, Scigliano E, Fruchtman S.

Biol Blood Marrow Transplant. 2000;6(4A):428-33.


Supplemental Content

Support Center